{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,8]],"date-time":"2025-10-08T00:23:31Z","timestamp":1759883011320,"version":"build-2065373602"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T00:00:00Z","timestamp":1759795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"National Institutes of Health (NIH), National Cancer Institute (NCI), United States of America","award":["5U54CA190151-02 and 5U54CA254518-03"],"award-info":[{"award-number":["5U54CA190151-02 and 5U54CA254518-03"]}]},{"name":"National Institutes of Health (NIH), United States of America","award":["D43TW011317"],"award-info":[{"award-number":["D43TW011317"]}]},{"name":"Providence\/Boston CFAR, United States of America","award":["P30AI042853"],"award-info":[{"award-number":["P30AI042853"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-18664-w","type":"journal-article","created":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:44:22Z","timestamp":1759844662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Scalable long-read nanopore HPV16 amplicon-based whole-genome sequencing"],"prefix":"10.1038","volume":"15","author":[{"given":"Maina K.","family":"Titus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Giesbrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cliff I.","family":"Oduor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kapten","family":"Muthoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karamoko","family":"Niar\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Crudale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abebe A.","family":"Fola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sin Ting","family":"Hui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Isaac E.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip K.","family":"Tonui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter M.","family":"Itsura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald","family":"Tonui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann M.","family":"Moormann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J.","family":"Loehrer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Darron R.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omenge E.","family":"Orang\u2019o","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Cu-Uvin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron C.","family":"Ermel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel A.","family":"Katzenellenbogen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,7]]},"reference":[{"key":"18664_CR1","doi-asserted-by":"publisher","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians vol. 71 209\u2013249 Preprint at https:\/\/doi.org\/10.3322\/caac.21660 (2021).","DOI":"10.3322\/caac.21660"},{"key":"18664_CR2","doi-asserted-by":"publisher","first-page":"3037","DOI":"10.1002\/ijc.33120","volume":"147","author":"M Sengayi-Muchengeti","year":"2020","unstructured":"Sengayi-Muchengeti, M. et al. Cervical cancer survival in sub-Saharan Africa by age, stage at diagnosis and Human Development Index: A population-based registry study. Int. J. Cancer 147, 3037\u20133048 (2020).","journal-title":"Int. J. Cancer"},{"key":"18664_CR3","unstructured":"World Health Organization. Global Strategy to Accelerate the Elimination of Cervical Cancer as a Public Health Problem."},{"key":"18664_CR4","doi-asserted-by":"publisher","first-page":"3050","DOI":"10.1038\/s41591-023-02600-4","volume":"29","author":"KT Simms","year":"2023","unstructured":"Simms, K. T. et al. Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population. Nat. Med. 29, 3050\u20133058 (2023).","journal-title":"Nat. Med."},{"key":"18664_CR5","unstructured":"Recommendations and Good Practice Statements on Screening and Treatment to Prevent Cervical Cancer. (World Health Organization, 2021)."},{"key":"18664_CR6","doi-asserted-by":"publisher","first-page":"101645","DOI":"10.1016\/j.eclinm.2022.101645","volume":"53","author":"H Kelly","year":"2022","unstructured":"Kelly, H. et al. Diagnostic accuracy of cervical cancer screening strategies for high-grade cervical intraepithelial neoplasia (CIN2+\/CIN3+) among women living with HIV: a systematic review and meta-analysis. EClinicalMedicine 53, 101645 (2022).","journal-title":"EClinicalMedicine"},{"key":"18664_CR7","doi-asserted-by":"publisher","first-page":"3059","DOI":"10.1038\/s41591-023-02601-3","volume":"29","author":"MT Hall","year":"2023","unstructured":"Hall, M. T. et al. Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV. Nat. Med. 29, 3059\u20133066 (2023).","journal-title":"Nat. Med."},{"key":"18664_CR8","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.virol.2018.01.002","volume":"516","author":"Z Chen","year":"2018","unstructured":"Chen, Z. et al. Classification and evolution of human papillomavirus genome variants: Alpha-5 (HPV26, 51, 69, 82), Alpha-6 (HPV30, 53, 56, 66), Alpha-11 (HPV34, 73), Alpha-13 (HPV54) and Alpha-3 (HPV61). Virology 516, 86\u2013101 (2018).","journal-title":"Virology"},{"key":"18664_CR9","doi-asserted-by":"crossref","unstructured":"Mirabello, L. et al. HPV16 Sublineage Associations With Histology-Specific Cancer Risk Using HPV Whole-Genome Sequences in 3200 Women. JNCI: Journal of the National Cancer Institute 108, (2016).","DOI":"10.1093\/jnci\/djw100"},{"key":"18664_CR10","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1016\/j.pvr.2019.02.001","volume":"7","author":"GM Clifford","year":"2019","unstructured":"Clifford, G. M. et al. Human papillomavirus 16 sub-lineage dispersal and cervical cancer risk worldwide: whole viral genome sequences from 7116 HPV16-positive women. Papillomavirus Res. 7, 67\u201374 (2019).","journal-title":"Papillomavirus Res."},{"key":"18664_CR11","doi-asserted-by":"publisher","first-page":"904","DOI":"10.3390\/v16060904","volume":"16","author":"L Galati","year":"2024","unstructured":"Galati, L., Di Bonito, P., Marinaro, M., Chiantore, M. V. & Gheit, T. HPV16 phylogenetic variants in anogenital and head and neck cancers: state of the art and perspectives. Viruses 16, 904 (2024).","journal-title":"Viruses"},{"key":"18664_CR12","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1002\/ijc.30401","volume":"139","author":"W Chen","year":"2016","unstructured":"Chen, W. et al. The variable clinicopathological categories and role of human papillomavirus in cervical adenocarcinoma: a hospital based nation-wide multi-center retrospective study across China. Int. J. Cancer 139, 2687\u20132697 (2016).","journal-title":"Int. J. Cancer"},{"key":"18664_CR13","doi-asserted-by":"publisher","first-page":"F32","DOI":"10.1016\/j.vaccine.2012.07.092","volume":"31","author":"H De Vuyst","year":"2013","unstructured":"De Vuyst, H. et al. The Burden of human papillomavirus infections and related diseases in Sub-Saharan Africa. Vaccine 31, F32\u2013F46 (2013).","journal-title":"Vaccine"},{"key":"18664_CR14","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1186\/s12879-019-3982-7","volume":"19","author":"A Ermel","year":"2019","unstructured":"Ermel, A. et al. A cross-sectional analysis of factors associated with detection of oncogenic human papillomavirus in human immunodeficiency virus-infected and uninfected Kenyan women. BMC Infect. Dis. 19, 352 (2019).","journal-title":"BMC Infect. Dis."},{"key":"18664_CR15","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13027-016-0102-9","volume":"11","author":"A Ermel","year":"2016","unstructured":"Ermel, A. et al. Invasive cervical cancers in the United States, Botswana and Kenya: HPV type distribution and health policy implications. Infect. Agent. Cancer 11, 56 (2016).","journal-title":"Infect. Agent. Cancer"},{"key":"18664_CR16","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1038\/s41588-020-0673-7","volume":"52","author":"A Gagliardi","year":"2020","unstructured":"Gagliardi, A. et al. Analysis of Ugandan cervical carcinomas identifies human papillomavirus clade-specific epigenome and transcriptome landscapes. Nat. Genet. 52, 800\u2013810 (2020).","journal-title":"Nat. Genet."},{"key":"18664_CR17","doi-asserted-by":"publisher","first-page":"e191","DOI":"10.1016\/S2214-109X(19)30482-6","volume":"8","author":"M Arbyn","year":"2020","unstructured":"Arbyn, M. et al. Estimates of incidence and mortality of cervical cancer in 2018: a worldwide analysis. Lancet Glob Health 8, e191\u2013e203 (2020).","journal-title":"Lancet Glob Health"},{"key":"18664_CR18","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1093\/jnci\/dju270","volume":"106","author":"LF Xi","year":"2014","unstructured":"Xi, L. F. et al. Lineages of oncogenic human papillomavirus types other than type 16 and 18 and risk for cervical intraepithelial neoplasia. J. Natl. Cancer Inst. 106, 270 (2014).","journal-title":"J. Natl. Cancer Inst."},{"key":"18664_CR19","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.virol.2013.07.018","volume":"445","author":"RD Burk","year":"2013","unstructured":"Burk, R. D., Harari, A. & Chen, Z. Human papillomavirus genome variants. Virology 445, 232\u2013243 (2013).","journal-title":"Virology"},{"key":"18664_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.pvr.2015.05.004","volume":"1","author":"M Cullen","year":"2015","unstructured":"Cullen, M. et al. Deep sequencing of HPV16 genomes: a new high-throughput tool for exploring the carcinogenicity and natural history of HPV16 infection. Papillomavirus Res. 1, 3\u201311 (2015).","journal-title":"Papillomavirus Res."},{"key":"18664_CR21","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.3390\/v16081314","volume":"16","author":"C Maueia","year":"2024","unstructured":"Maueia, C. et al. Identification of HPV16 lineages in South African and Mozambican women with normal and abnormal cervical cytology. Viruses 16, 1314 (2024).","journal-title":"Viruses"},{"key":"18664_CR22","doi-asserted-by":"publisher","first-page":"2492","DOI":"10.3390\/microorganisms10122492","volume":"10","author":"P Iglesias","year":"2022","unstructured":"Iglesias, P. et al. Characterization of human Papillomavirus 16 from Kinshasa (Democratic Republic of the Congo)-implications for pathogenicity and vaccine effectiveness. Microorganisms 10, 2492 (2022).","journal-title":"Microorganisms"},{"key":"18664_CR23","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/s12879-022-07081-3","volume":"22","author":"L Tawe","year":"2022","unstructured":"Tawe, L. et al. Genetic diversity in L1 ORF of human papillomavirus in women with cervical cancer with and without human immunodeficiency virus in Botswana and Kenya. BMC Infect. Dis. 22, 95 (2022).","journal-title":"BMC Infect. Dis."},{"key":"18664_CR24","doi-asserted-by":"publisher","unstructured":"Tegally, H. et al. The evolving SARS-CoV-2 epidemic in Africa: Insights from rapidly expanding genomic surveillance. https:\/\/doi.org\/10.1101\/2022.04.17.22273906. (2022)","DOI":"10.1101\/2022.04.17.22273906"},{"key":"18664_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1038\/nature16996","volume":"530","author":"J Quick","year":"2016","unstructured":"Quick, J. et al. Real-time, portable genome sequencing for Ebola surveillance. Nature 530, 228\u2013232 (2016).","journal-title":"Nature"},{"key":"18664_CR26","doi-asserted-by":"crossref","unstructured":"Yu, S. et al. Nanopore sequencing for precise detection of Mycobacterium tuberculosis and drug resistance: a retrospective multicenter study in China. J. Clin. Microbiol. e0181324 (2025).","DOI":"10.1128\/jcm.01813-24"},{"key":"18664_CR27","unstructured":"Van Der Auwera, G. A. & Connor, O. Genomics in the Cloud: Using Docker, GATK, and WDL in Terra. (Sebastopol: O\u2019Reilly Media, 2020)."},{"key":"18664_CR28","doi-asserted-by":"publisher","unstructured":"Poplin, R. et al. Scaling accurate genetic variant discovery to tens of thousands of samples. bioRxiv (2017) https:\/\/doi.org\/10.1101\/201178.","DOI":"10.1101\/201178"},{"key":"18664_CR29","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1038\/s41592-021-01299-w","volume":"18","author":"K Shafin","year":"2021","unstructured":"Shafin, K. et al. Haplotype-aware variant calling with PEPPER-Margin-DeepVariant enables high accuracy in nanopore long-reads. Nat. Methods 18, 1322\u20131332 (2021).","journal-title":"Nat. Methods"},{"key":"18664_CR30","doi-asserted-by":"publisher","DOI":"10.21203\/rs.3.rs-1881940\/v1","author":"R Luo","year":"2022","unstructured":"Luo, R. et al. Symphonizing pileup and full-alignment for deep learning-based long-read variant calling. Research Square https:\/\/doi.org\/10.21203\/rs.3.rs-1881940\/v1 (2022).","journal-title":"Research Square"},{"key":"18664_CR31","doi-asserted-by":"publisher","first-page":"100128","DOI":"10.1016\/j.xgen.2022.100128","volume":"2","author":"J Wagner","year":"2022","unstructured":"Wagner, J. et al. Benchmarking challenging small variants with linked and long reads. Cell Genom. 2, 100128 (2022).","journal-title":"Cell Genom."},{"key":"18664_CR32","doi-asserted-by":"publisher","first-page":"e1006211","DOI":"10.1371\/journal.ppat.1006211","volume":"13","author":"AA McBride","year":"2017","unstructured":"McBride, A. A. & Warburton, A. The role of integration in oncogenic progression of HPV-associated cancers. PLoS Pathog. 13, e1006211 (2017).","journal-title":"PLoS Pathog."},{"key":"18664_CR33","doi-asserted-by":"publisher","first-page":"1483","DOI":"10.1038\/s41592-023-01993-x","volume":"20","author":"M Kolmogorov","year":"2023","unstructured":"Kolmogorov, M. et al. Scalable Nanopore sequencing of human genomes provides a comprehensive view of haplotype-resolved variation and methylation. Nat. Methods 20, 1483\u20131492 (2023).","journal-title":"Nat. Methods"},{"key":"18664_CR34","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13027-021-00355-6","volume":"16","author":"G Murenzi","year":"2021","unstructured":"Murenzi, G. et al. Type-specific persistence, clearance and incidence of high-risk HPV among screen-positive Rwandan women living with HIV. Infect. Agent. Cancer 16, 16 (2021).","journal-title":"Infect. Agent. Cancer"},{"key":"18664_CR35","doi-asserted-by":"publisher","first-page":"e1007352","DOI":"10.1371\/journal.ppat.1007352","volume":"14","author":"Z Chen","year":"2018","unstructured":"Chen, Z. et al. Niche adaptation and viral transmission of human papillomaviruses from archaic hominins to modern humans. PLoS Pathog. 14, e1007352 (2018).","journal-title":"PLoS Pathog."},{"key":"18664_CR36","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1093\/molbev\/msw214","volume":"34","author":"VN Pimenoff","year":"2016","unstructured":"Pimenoff, V. N., de Oliveira, C. M. & Bravo, I. G. Transmission between Archaic and modern human ancestors during the evolution of the oncogenic human papillomavirus 16. Mol. Biol. Evol. 34, 4\u201319 (2016).","journal-title":"Mol. Biol. Evol."},{"key":"18664_CR37","doi-asserted-by":"crossref","unstructured":"Liu, Y., Pan, Y., Gao, W., Ke, Y. & Lu, Z. Whole-genome analysis of human Papillomavirus types 16, 18, and 58 isolated from cervical precancer and cancer samples in Chinese women. Sci. Rep. 7, (2017).","DOI":"10.1038\/s41598-017-00364-9"},{"key":"18664_CR38","doi-asserted-by":"publisher","first-page":"1163","DOI":"10.1038\/s41416-018-0311-7","volume":"119","author":"LS Arroyo-M\u00fchr","year":"2018","unstructured":"Arroyo-M\u00fchr, L. S. et al. Human papillomavirus type 16 genomic variation in women with subsequent in situ or invasive cervical cancer: prospective population-based study. Br. J. Cancer 119, 1163\u20131168 (2018).","journal-title":"Br. J. Cancer"},{"key":"18664_CR39","doi-asserted-by":"publisher","first-page":"114180","DOI":"10.1016\/j.jviromet.2021.114180","volume":"294","author":"RN Brancaccio","year":"2021","unstructured":"Brancaccio, R. N. et al. MinION nanopore sequencing and assembly of a complete human papillomavirus genome. J. Virol. Methods 294, 114180 (2021).","journal-title":"J. Virol. Methods"},{"key":"18664_CR40","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1038\/s41592-020-01041-y","volume":"18","author":"SM Karst","year":"2021","unstructured":"Karst, S. M. et al. High-accuracy long-read amplicon sequences using unique molecular identifiers with Nanopore or PacBio sequencing. Nat. Methods 18, 165\u2013169 (2021).","journal-title":"Nat. Methods"},{"key":"18664_CR41","doi-asserted-by":"publisher","first-page":"5029","DOI":"10.1038\/s41467-019-13036-1","volume":"10","author":"JS Johnson","year":"2019","unstructured":"Johnson, J. S. et al. Evaluation of 16S rRNA gene sequencing for species and strain-level microbiome analysis. Nat. Commun. 10, 5029 (2019).","journal-title":"Nat. Commun."},{"key":"18664_CR42","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1086\/426867","volume":"191","author":"DR Brown","year":"2005","unstructured":"Brown, D. R. et al. A longitudinal study of genital human papillomavirus infection in a cohort of closely followed adolescent women. J. Infect. Dis. 191, 182\u2013192 (2005).","journal-title":"J. Infect. Dis."},{"key":"18664_CR43","doi-asserted-by":"publisher","first-page":"D499","DOI":"10.1093\/nar\/gkw879","volume":"45","author":"K Van Doorslaer","year":"2017","unstructured":"Van Doorslaer, K. et al. The papillomavirus episteme: a major update to the papillomavirus sequence database. Nucleic Acids Res. 45, D499\u2013D506 (2017).","journal-title":"Nucleic Acids Res."},{"key":"18664_CR44","doi-asserted-by":"publisher","first-page":"350","DOI":"10.3390\/v11040350","volume":"11","author":"Y Hirose","year":"2019","unstructured":"Hirose, Y. et al. Whole-genome analysis of human Papillomavirus type 16 prevalent in Japanese women with or without cervical lesions. Viruses 11, 350 (2019).","journal-title":"Viruses"},{"key":"18664_CR45","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1101\/gr.215087.116","volume":"27","author":"S Koren","year":"2017","unstructured":"Koren, S. et al. Canu: scalable and accurate long-read assembly via adaptive k-mer weighting and repeat separation. Genome Res. 27, 722\u2013736 (2017).","journal-title":"Genome Res."},{"key":"18664_CR46","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41598-018-36669-6","volume":"9","author":"S Lagstr\u00f6m","year":"2019","unstructured":"Lagstr\u00f6m, S. et al. TaME-seq: An efficient sequencing approach for characterisation of HPV genomic variability and chromosomal integration. Sci. Rep. 9, 524 (2019).","journal-title":"Sci. Rep."},{"issue":"Pt 7","key":"18664_CR47","doi-asserted-by":"publisher","first-page":"1725","DOI":"10.1099\/0022-1317-80-7-1725","volume":"80","author":"JD Meissner","year":"1999","unstructured":"Meissner, J. D. Nucleotide sequences and further characterization of human papillomavirus DNA present in the CaSki, SiHa and HeLa cervical carcinoma cell lines. J. Gen. Virol. 80(Pt 7), 1725\u20131733 (1999).","journal-title":"J. Gen. Virol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18664-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18664-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18664-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,7]],"date-time":"2025-10-07T13:44:25Z","timestamp":1759844665000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-18664-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,7]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["18664"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-18664-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,7]]},"assertion":[{"value":"29 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All participants provided written informed consent. Ethical approvals were obtained from the Institutional Research and Ethics Committee (IREC) of Moi Teaching and Referral Hospital (MTRH) and Moi University, Eldoret, Kenya (reference number IREC\/371\/2022) and from the Institutional Review Board (IRB) of Brown University, Providence, Rhode Island, USA (IRB-ID: 2,023,003,553). All study procedures were performed in accordance with relevant guidelines and regulations outlined by the Ethics Review Boards indicated above.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical statement"}}],"article-number":"34892"}}